A New Approach to Women's Sexual Health
Desire often is linked to a sense of closeness between partners, as well as sexual issues from the past.
Is Addyi right for me?
While sexual dysfunction affects both men and women, men have 26 FDA-approved treatments to choose from. A new documentary explains that it’s in part because the FDA drug approval process determines which sexual health options are available, and how restrictions or labeling decisions can limit access for certain groups. “When you look at women — premenopausal, postmenopausal, transgender individuals — the conversation of what is available to you is not dictated by you,” explains Johns Hopkins Carey Business School Law and Ethics Professor Stacey Lee in The Pink Pill: Sex, Drugs & Who Has Control. Addyi, or flibanserin, treats Hypoactive Sexual Desire Disorder, a common condition defined by lack of sexual desire in women. It has yet to achieve the same kind of widespread use or acceptance as men’s Viagra, which is used by millions of patients annually since its 1998 debut.
McClatchy: FDA Approves First-Ever Drug For Women With Low Sexual Desire
The Pink Pill recounts the journey of Sprout Pharmaceuticals Founder and CEO Cindy Eckert, the entrepreneur whose company developed and brought Addyi to market, as she set out to expand access for sexual health treatments for women. Eckert’s path in developing Addyi for patient use was more of a struggle than it should’ve been, according to the documentary, which calls out the inequalities in availability of sexual health treatment between men and women. Lee highlights that FDA choices and approvals are not just regulatory decisions, but that they also shape who can get care and how easily. “If you’re a cisgender, white male, health care in the United States is pretty darn good, and your health care experience can be a uniquely personal one,” she said. In other words, women and minority groups often don’t have a similar, positive experience.
The Queens: Chaka Khan, Patti LaBelle & Stephanie Mills
“FDA decisions are not just scientific determinations, but structural choices that shape access, risk, and who benefits from innovation,” said Lee. The FDA declined approval for Addyi in 2010 and 2013, with some critics referring to the treatment as “an ineffective drug for a nonexistent cheap viagra with dapoxetine problem.” However, data from the University of Colorado Anschutz Department of Obstetrics and Gynecology shows that 10% of women across all age groups suffer from HSDD, which can “cause significant levels of personal distress.” To put it into perspective, HSDD is just as common as autoimmune disorders like rheumatoid arthritis, and in the U.S. alone there are nearly a million patients taking oral medication to treat their autoimmune condition. Though HSDD is not a threat to physical wellbeing, both conditions can have significant impact on a person’s life. Like most medications, Addyi doesn’t work for everyone, but its availability gives women struggling with HSDD an option that otherwise doesn’t exist. Some chronic conditions, such as diabetes or multiple sclerosis, can cause changes in arousal or orgasm. If you have trouble with sexual desire or response, talk with a member of your healthcare team.
| Aspect | Data/Statistics | Notes |
|---|---|---|
| Global Market Size | Estimated at $500 million in 2023 | Growing in popularity |
| Age Group | Mainly 30-50 years old | Peak demand |
| Gender | Primarily male consumers | Focus of marketing |
| Regional Popularity | higher in North America and Europe | Cultural acceptance varies |
| Purchase Channels | Online pharmacies, clinics | Discreet, convenient options |
You might want to talk to a sex therapist. Medicines, hormones, creams, lubricants, clitoral stimulation or other treatments sometimes can help. There is a problem with information submitted for this request.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Viagra Generic | 50mg | 270 + 8 Pills | 198.48€ 189.03€ | |
| Viagra Generic | 200mg | 20 Pills | 61.69€ 58.75€ | |
| Viagra Super Active | 100mg | 180 + 20 Pills | 280.97€ 267.59€ | |
| Viagra Generic | 100mg | 360 + 10 Pills | 330.21€ 314.49€ | |
| Viagra Generic | 150mg | 30 + 2 Pills | 72.32€ 68.88€ | |
| Viagra Oral Jelly | 100mg | 63 + 7 Sachets | 190.54€ 181.47€ | |
| Viagra Generic | 25mg | 20 Pills | 37.74€ 35.94€ | |
| Viagra Generic | 150mg | 360 + 10 Pills | 423.48€ 403.31€ | |
| Viagra Generic | 150mg | 270 + 10 Pills | 326.61€ 311.06€ | |
| Viagra Generic | 200mg | 30 + 2 Pills | 83.07€ 79.11€ | |
| Viagra Professional | 100mg | 90 + 2 Pills | 207.09€ 197.23€ |
Review/update the information highlighted below and resubmit the form. Women’s health topics - straight to your inbox Get the latest information from our Mayo Clinic viagra over the counter experts on women’s health topics, serious and complex conditions, wellness and more.
Desire Starts in the Brain...
Many factors can affect sexual desire in women. Many women find that the stresses of daily life lower their desire for sex. Highs and lows in sexual desire may go along with the beginning or end of a relationship or with major life changes, such as pregnancy or menopause. For some women, orgasm can be hard to reach. This can cause worries that lead to a loss of interest in sex. Click to view a preview and subscribe below.
ABC News Live Presents
In 2019 and after additional research was conducted, the FDA modified its original alcohol warning for Addyi and removed the test requirement for doctors and pharmacists. In December of 2025, the FDA approved the drug for postmenopausal women, expanding access to more patients. Advocates say a drug to treat women’s sexual dysfunction is a start to addressing health inequity. Lee adds that recent bigger picture events, though, like the overturn of Roe v. Wade and rollbacks on birth control access, have changed what health care looks like for women today.
Impact X Nightline: It's Britney
The approval and acceptance of Addyi is part of a much larger and ongoing conversation about women’s health and regulatory policy currently. “The past five to 10 years really calls into question where the state of women’s health is going,” Lee said. The Pink Pill: Sex, Drugs & Who Has Control is streaming on Paramount+ in Canada and the U.S. as of March 6, 2026. Given the success of medicines to treat trouble getting and keeping an erection, called erectile dysfunction, companies have looked for a medicine to help women with sex.
24 Months That Changed the World
Viagra even has been tried as a treatment for sexual dysfunction in women. But the U.S. Food and Drug Administration (FDA) hasn't approved this use of Viagra. For years there were no FDA-approved medicines for treating problems with sexual arousal or sexual desire in women. Yet 4 in 10 women report having sexual concerns. Learn more about Mayo Clinic’s use of data. We use the data you provide to deliver you the content you requested.
The #1 Prescribed Treatment for frustrating Low Libido1
Still, early research didn’t quite satisfy the FDA. “When the data first went up viagra red for review in 2010, the FDA did not feel that there was enough data to support Addyi’s effectiveness,” said Lee. The drug was originally tested in a clinical trial with over 2,000 premenopausal women either taking Addyi or a placebo pill. Participants taking Addyi were 10% more likely to report an increase in satisfying sexual events. A more recent study found that about half of women taking Addyi reported benefit to their sex life.
Linsey Davis Reports: The Epstein Survivors Speak Out
Advocates for women’s health criticized the FDA’s early rejections and claimed gender bias, especially because Viagra was approved under an expedited priority review process, taking less than a year to achieve approval. Though the purposes of Addyi and Viagra are similar, Addyi corrects chemical imbalances of certain neurotransmitters in the brain that are responsible for sexual desire or excitement, which makes the drug approval process more complex. “Erectile dysfunction was seen as an unmet physical ailment,” said Lee. Because of that, Viagra was evaluated as treatment to address a physical need. HSDD was not considered an unmet physical ailment in the eyes of the FDA but rather an unmet psychological ailment, which “immediately triggers a higher standard of review and additional safety measures,” Lee adds.
Search for missing after deadly chemical tank rupture in Washington
While the drugs had to be evaluated differently, supporters of Addyi claimed that stigma and overly cautious FDA warnings deterred patient use even after it was approved. For example, doctors and pharmacists had to take a test, known as a Risk Evaluation and Mitigation Strategy assessment, to prescribe and administer Addyi. The assessment included an online slide presentation followed by a comprehension test that proved the medical professionals knew and understood the drug’s risks of potential low blood pressure and fainting when combined with alcohol. Even further, patients had to sign a paper vowing not to drink while on the medication even though Cialis--another medication used to treat erectile dysfunction in men--creates similar interactions with alcohol but comes with no more than an advisement to moderate alcohol use. At the time of approval, the FDA argued that Addyi’s interaction with alcohol hadn’t yet been adequately studied. To provide you with the most relevant and helpful information, we may combine your email and website data with other information we have about you. If you are a Mayo Clinic patient, we will only use your protected health information as outlined in our Notice of Privacy Practices. You may opt out of email communications at any time by clicking on the unsubscribe link in the email.
- Pink Viagra is generally not recommended for women or non-binary individuals.
- Some products claim to improve female sexual arousal but lack evidence.
- FDA-approved medications for women include Flibanserin and Addyi.
- Pink Viagra labeled products are often unregulated for female use.
- Women should consult healthcare providers for safe options.
- Misuse of pink Viagra-type products can cause adverse effects in women.
- There is increased research into authorized female sexual enhancement drugs.
- Marketing claims about pink Viagra for women are often exaggerated.
- Reliable sexual health products should be prescribed or approved.
You'll soon start receiving the latest Mayo Clinic health information you requested in your inbox.
Albino buffalo spared from sacrifice due to Trump likeness
The FDA now has approved two medicines. The FDA has approved a daily pill called flibanserin (Addyi) to treat low sexual desire in women before menopause. This medicine started as a treatment for depression. Addyi may boost sex drive in women with low sexual desire. It's for women who are not happy with their low sex drive.
Drug interactions
Possible serious side effects include low blood pressure, dizziness and fainting. These side effects are more likely to happen if the medicine is mixed with alcohol. The FDA says not to drink alcohol if you take this medicine. Experts suggest that you stop taking the medicine if your sex drive doesn't improve after eight weeks. The FDA also has approved a medicine given as a shot to treat low sexual desire in women before menopause.
All Access With Linsey Davis: Jeremy Allen White
Bremelanotide (Vyleesi) is injected under the skin in the belly or thigh at least 45 minutes before having sex. It should not be used more than once a day or more than eight times a month. Side effects can include nausea, headache, vomiting and reactions at the site of the shot. Talk with your healthcare professional to see if this medicine might be right for you. Sexual problems may be due to trouble with arousal, a lack of desire or both. American Association for Marriage and Family Therapy. Overview of sexual dysfunction in women: Management. The FDA Reproductive Health Advisory Committee met on June 18, 2010 to discuss approval of Flibanserin for “hypoactive sexual desire disorder,” or low sexual desire.
- Pink Viagra is sometimes linked to the youthful or trendy image.
- Social media influencers may promote pink Viagra products.
- Its popularity spikes among young adults seeking performance enhancement.
- There is a misconception that pink Viagra is completely safe or natural.
- Many pink Viagra ads use suggestive language to attract buyers.
- The use of pink Viagra without medical advice can be risky.
- Cultural factors influence the popularity of pink Viagra in different regions.
- Education about safe sexual health practices is essential.
- Consumers should prioritize substances backed by scientific evidence.
This drug is specifically meant to treat this condition in women.
- Pink Viagra is linked to the broader category of sexual wellness products.
- It competes with herbal supplements and other natural remedies.
- The market is driven by increasing awareness of sexual health.
- Consumers are advised to choose products with regulatory approval.
- Unscrupulous vendors often exploit demand with false claims.
- Regular medical check-ups are recommended for ongoing sexual issues.
- Personalized treatment plans are more effective than over-the-counter products.
- Comprehensive sexual health education reduces reliance on unverified solutions.
- Research continues into safe and effective sexual enhancement options.
NRC president Diana Zuckerman recommended against approval of Flibanserin (see her comments in Rodale News) and the FDA advisory committee agreed, voting against approval of Flibanserin. Women on placebo improved almost exactly as much as those on the drug in the U.S.
- Pink Viagra products sometimes come with misleading advertising claims.
- They often promise instant or dramatic sexual performance improvements.
- Many pink Viagra supplements have no clinical testing or approval.
- The trade name "Pink Viagra" is not an official pharmaceutical name.
- There are risks associated with counterfeit or substandard pink Viagra pills.
- Some users experience allergic reactions to unknown ingredients.
- The market for pink Viagra is flooded with low-quality or harmful products.
- Regulatory agencies detect and shut down illegal pink Viagra sales.
- Public awareness campaigns target unregulated sexual enhancement supplements.